Jul. 8 at 12:06 AM
$XERS FYI. If we hold the current price next 4 trading days that will be a VWAP of
$7.75
With the
$10 billion Crinetics buyout today it seems we would easily get
$4-
$5 billion offers. Without a cancer drug pipeline I don't think a buyout is in the cards though.
I think our assets will do us well but I am not sure we are a likely target in the near term.
Also remember that our fair value should be somewhere around
$13 or so based on industry averages when thinking about charts and other metrics. No reason we couldn't have a run to that by November or possibly sooner.
It is going to be pretty difficult to guess what this will be at any time in the next 4-5 years.
Could steady go up or have some wild action in any direction especially after another run.
I don't really consider this a big run since I am still down from November last year. I would consider
$12 or
$13 a decent run personally.
